Previous studies report that miR-137 suppressed cell migration and invasion by targeting PXN, therefore providing a potential therapy for NSCLC by targeting miRNA expression (Dacic et al., 2010; Bi et al., 2014). The gene discussed is PXN; the disease is non-small cell lung carcinoma.